ArticlePloS one2026

Study protocol: A randomized controlled trial of chemoradiotherapy versus chemotherapy as neoadjuvant therapy for resectable pancreatic cancer (CSGO-HBP-027).

Yoshito Tomimaru et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.